Tectonic Therapeutic, Inc.
NASDAQ Global MarketTotal Valuation
Tectonic Therapeutic, Inc. carries a market capitalization of 536.26M, placing it among publicly traded companies globally. Its enterprise value stands at 346.37M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 536.26M |
| Enterprise Value | 346.37M |
Share Statistics
Tectonic Therapeutic, Inc. currently has 18.83M shares outstanding.
| Shares Outstanding | 18.83M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -2.33 |
| P/TBV Ratio | 2.51 |
| P/FCF Ratio | -8.87 |
| P/OCF Ratio | -8.85 |
Financial Position
Tectonic Therapeutic, Inc. maintains a current ratio of 18.51, meaning it holds 18.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 2.01, indicating elevated leverage, while an interest coverage ratio of -1,798.43 demonstrates limited ability to service its debt obligations.
| Current Ratio | 18.51 |
| Quick Ratio | 18.28 |
| Debt / Equity | 2.01 |
| Debt / EBITDA | -0.05 |
| Interest Coverage | -1,798.43 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -29.74 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
| Income Tax | 1.23M |
| Effective Tax Rate | N/A |
Stock Price Statistics
Tectonic Therapeutic, Inc.'s stock has gained approximately 25.41924% over the past 52 weeks. The 50-day moving average sits at 29.17, while the 200-day moving average is 22.77.
| Beta (5Y) | N/A |
| 52-Week Price Change | 25.41924% |
| 50-Day Moving Average | 29.17 |
| 200-Day Moving Average | 22.77 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -91.72M, while operating income came in at -93.04M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -93.04M |
| Pretax Income | -82.26M |
| Net Income | -83.49M |
| EBITDA | -91.72M |
| EBIT | -93.04M |
| Earnings Per Share (EPS) | -4.46 |
Balance Sheet
Tectonic Therapeutic, Inc. holds 236.89M in cash and equivalents against 4.63M in total debt, resulting in a net debt position of -236.89M. Total book value stands at -247.98M, with working capital of 226.93M providing operational flexibility.
| Cash & Cash Equivalents | 236.89M |
| Total Debt | 4.63M |
| Net Debt | -236.89M |
| Equity (Book Value) | -247.98M |
| Book Value Per Share | -13.25 |
| Working Capital | 226.93M |
Cash Flow
Tectonic Therapeutic, Inc. produced -65.41M in operating cash flow over the past twelve months. After subtracting -200,000.00 in capital expenditures, free cash flow totaled -65.61M - equivalent to -3.50 per share.
| Operating Cash Flow | -65.41M |
| Capital Expenditures | -200,000.00 |
| Free Cash Flow | -65.61M |
| FCF Per Share | -3.50 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 0.68 |
| FCF Yield | -11.27 |
Stock Splits
Tectonic Therapeutic, Inc.'s most recent stock split took place on June 21, 2024 with a 12:1 split ratio.
| Last Split Date | 6/21/2024 |
| Split Ratio | 12:1 |
Scores
Tectonic Therapeutic, Inc. posts an Altman Z-Score of 19.94, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 19.94 |